{"transactions":[{"id":748095,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-05T20:29:24.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001780081-26-000006","document":"form4-06052026_080620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000178008126000006/form4-06052026_080620.xml","form_type":"4"}},{"id":846289,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T20:56:06.000Z","date":"2026-03-10","kind":"sale","planned":true,"acquired":false,"shares":33243,"price":39.7366,"value":1320963.7938,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.11 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":283302,"source":{"system":"sec-edgar","filing":"0001780081-26-000004","document":"form4-03122026_080302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000178008126000004/form4-03122026_080302.xml","form_type":"4"}},{"id":861729,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-04T21:28:40.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":7229,"price":39.6618,"value":286715.1522,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.80 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":316545,"source":{"system":"sec-edgar","filing":"0001780081-26-000002","document":"form4-03042026_090337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000178008126000002/form4-03042026_090337.xml","form_type":"4"}},{"id":987197,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-26T21:06:48.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":40472,"price":29.7173,"value":1202718.5656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.12 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":323774,"source":{"system":"sec-edgar","filing":"0001780081-25-000006","document":"form4-11262025_091144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000178008125000006/form4-11262025_091144.xml","form_type":"4"}},{"id":995870,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T21:22:26.000Z","date":"2025-11-14","kind":"sale","planned":true,"acquired":false,"shares":20682,"price":27.3361,"value":565365.2202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.98 to $27.88 per share, inclusive."}],"balance_after":364246,"source":{"system":"sec-edgar","filing":"0001780081-25-000004","document":"form4-11182025_091122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000178008125000004/form4-11182025_091122.xml","form_type":"4"}},{"id":995869,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T21:22:26.000Z","date":"2025-11-14","kind":"sale","planned":true,"acquired":false,"shares":19790,"price":26.6141,"value":526693.039,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.975 to $26.97 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3."}],"balance_after":384928,"source":{"system":"sec-edgar","filing":"0001780081-25-000004","document":"form4-11182025_091122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000178008125000004/form4-11182025_091122.xml","form_type":"4"}},{"id":1123034,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-05T00:34:20.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":29747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2026 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":29747,"derivative":{"exercise_price":10.9,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":29747},"source":{"system":"sec-edgar","filing":"0001415889-25-015699","document":"form4-06052025_120617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000141588925015699/form4-06052025_120617.xml","form_type":"4"}},{"id":1486963,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-06-07T20:16:06.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":7639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 5, 2025 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":7639,"derivative":{"exercise_price":16.41,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":7639},"source":{"system":"sec-edgar","filing":"0001415889-24-015962","document":"form4-06072024_080601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000141588924015962/form4-06072024_080601.xml","form_type":"4"}},{"id":1854474,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-06-15T22:24:09.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":19441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall fully vest on June 13, 2024 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date."}],"balance_after":19441,"derivative":{"exercise_price":12.46,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":19441},"source":{"system":"sec-edgar","filing":"0001209191-23-037532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000120919123037532/doc4.xml","form_type":"4"}},{"id":2239177,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-08T21:00:37.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":12.96,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-22-035076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000120919122035076/doc4.xml","form_type":"4"}},{"id":2654875,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-06-25T20:58:17.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":11650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall fully vest on June 8, 2022 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's  continued service on such  vesting date."}],"balance_after":11650,"derivative":{"exercise_price":40.37,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":11650},"source":{"system":"sec-edgar","filing":"0001209191-21-043332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000120919121043332/doc4.xml","form_type":"4"}},{"id":3120667,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-06-05T21:27:51.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":14777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall fully vest on June 3, 2021 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's  continued service on such  vesting date."}],"balance_after":14777,"derivative":{"exercise_price":26.53,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":14777},"source":{"system":"sec-edgar","filing":"0001209191-20-034731","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000120919120034731/doc4.xml","form_type":"4"}},{"id":3416333,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-09-13T00:04:38.000Z","date":"2019-09-10","kind":"grant","acquired":true,"shares":14777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 100% and becomes exercisable on June 21, 2020, subject to reporting person's continued service through such vesting date."}],"balance_after":14777,"derivative":{"exercise_price":28.8,"expiration_date":"2029-09-09","underlying":"Common Stock","underlying_shares":14777},"source":{"system":"sec-edgar","filing":"0001567619-19-018220","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000156761919018220/doc1.xml","form_type":"4"}}]}